(Q47625320)

4 February 2018

title

Hope for BET inhibition in patients with leukaemia or lymphoma. (English)

1 reference

4 February 2018

1 reference

Mohamed A Kharfan-Dabaja

series ordinal

1

1 reference

4 February 2018

publication date

18 March 2016

1 reference

4 February 2018

published in

The Lancet. Haematology.

1 reference

4 February 2018

volume

3

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

e157-8

1 reference

4 February 2018

Targeting bromodomains: epigenetic readers of lysine acetylation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900253-7

7 January 2021

10.1016/S2352-3026(15)00253-7

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

27063970

1 reference

4 February 2018